Am J Cardiol
- SINGH S, Garg A, Tantry US, Bliden K, et al
Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without
Diabetes.
Am J Cardiol. 2024 Mar 1:S0002-9149(24)00161.
Am J Clin Nutr
- ZELICHA H, Yang J, Henning SM, Huang J, et al
Effect of cinnamon spice on continuously monitored glycemic response in adults
with prediabetes: a 4-week randomized controlled crossover trial.
Am J Clin Nutr. 2024;119:649-657.
- HUBER H, Schieren A, Holst JJ, Simon MC, et al
Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic
conditions - a narrative review.
Am J Clin Nutr. 2024 Jan 11:S0002-9165(24)00005.
Am J Manag Care
- HOFFMAN AF, Roberson CL, Cohen P, Jackson VL, et al
Improving glycemic control in diabetes through virtual interdisciplinary rounds.
Am J Manag Care. 2024;30:e78-e84.
- QUACH J, Midlam C, Sell C, Levin-Scherz J, et al
Out-of-pocket costs for diabetes medications in employer-sponsored health
insurance plans.
Am J Manag Care. 2024;30:107-108.
Am J Ophthalmol
- DAI Y, Zheng D, Zhao J, Wang K, et al
Macular Neural and Microvascular Alterations in Type 2 Diabetes Without
Retinopathy: A SS-OCT Study.
Am J Ophthalmol. 2024 Feb 28:S0002-9394(24)00090.
- JOSEPH S, Selvaraj J, Mani I, Kumaragurupari T, et al
Diagnostic accuracy of artificial intelligence based automated diabetic
retinopathy screening in real-world settings: a systematic review and
meta-analysis.
Am J Ophthalmol. 2024 Mar 2:S0002-9394(24)00066.
Ann Intern Med
- KOUTROUMPAKIS E, Deswal A
In adults with overweight or obesity and CVD, but without diabetes, semaglutide
reduced MACE at a mean 40 mo.
Ann Intern Med. 2024 Mar 5. doi: 10.7326/J24-0008.
Atherosclerosis
- KIM H, Choi CU, Rhew K, Park J, et al
Comparative effects of glucose-lowering agents on endothelial function and
arterial stiffness in patients with type 2 diabetes: A network meta-analysis.
Atherosclerosis. 2024;391:117490.
BMC Ophthalmol
- ZENG GQ, Yao YF, Zhong JB, Zhang Y, et al
The non-linear relationship between serum albumin and diabetic retinopathy in
type 2 diabetes mellitus: a secondary analysis based on a cross-sectional study.
BMC Ophthalmol. 2024;24:94.
BMJ
- TANNE JH
US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes,
says FDA.
BMJ. 2024;384:q569.
Circulation
- OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
Arterial Thromboembolism in Patients With Atrial Fibrillation and
CHA(2)DS(2)-VASc 1: A Nationwide Study.
Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
Diabet Med
- MERWIN RM, Dmitrieva NO, Moskovich AA, Warnick JL, et al
Profiles of disordered eating behaviour in type 1 diabetes using the DEPS-R and
behaviour and glycaemic outcomes in a real-life setting.
Diabet Med. 2024 Mar 7:e15314. doi: 10.1111/dme.15314.
- EMBAYE J, Hennekes M, Snoek F, de Wit M, et al
Psychometric properties of the Diabetes Eating Problem Survey-Revised among Dutch
adults with type 1 diabetes and implications for clinical use.
Diabet Med. 2024 Mar 4:e15313. doi: 10.1111/dme.15313.
- MONROY G, Fernandez C, Altimira L, Barba U, et al
Postpartum oral glucose tolerance test in women with prior gestational diabetes.
Does breastfeeding affect the results? Analysis of hormonal profiles.
Diabet Med. 2024 Mar 7:e15315. doi: 10.1111/dme.15315.
Diabetes Care
- SILVA PS, Cavallerano JD, Sun JK, Tolson AM, et al
Disparities Between Teleretinal Imaging Findings and Patient-Reported Diabetic
Retinopathy Status and Follow-Up Eye Care Interval: A 10-Year Prospective Study.
Diabetes Care. 2024 Mar 8:dc232282. doi: 10.2337/dc23-2282.
- SEIFU CN, Immanuel J, Hague WM, Teede H, et al
Association Between Immediate Treatment of Early Gestational Diabetes Mellitus
and Breastfeeding Outcomes: Findings From the TOBOGM Study.
Diabetes Care. 2024 Mar 5:dc231635. doi: 10.2337/dc23-1635.
Diabetes Obes Metab
- NERILD HH, Bronden A, Haddouchi AE, Ellegaard AM, et al
Elucidating the glucose-lowering effect of the bile acid sequestrant sevelamer.
Diabetes Obes Metab. 2024;26:1252-1263.
- HUANG Y, Wang S, Cai C, Huang X, et al
Retinal vascular density as a potential biomarker of diabetic cerebral small
vessel disease.
Diabetes Obes Metab. 2024 Mar 4. doi: 10.1111/dom.15492.
- HELMINK MAG, Hageman SHJ, Eliasson B, Sattar N, et al
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1
diabetes: The LIFE-T1D model.
Diabetes Obes Metab. 2024 Mar 8. doi: 10.1111/dom.15531.
- SOHN TS, Han KA, Kim Y, Lee BW, et al
A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an
add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M
extension study.
Diabetes Obes Metab. 2024 Mar 8. doi: 10.1111/dom.15537.
- POPOVIC DS, Patoulias D, Karakasis P, Koufakis T, et al
Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes.
Diabetes Obes Metab. 2024 Mar 8. doi: 10.1111/dom.15535.
- YANG J, Shangguan Q, Xie G, Yang M, et al
Sex-specific associations between haemoglobin glycation index and the risk of
cardiovascular and all-cause mortality in individuals with pre-diabetes and
diabetes: A large prospective cohort study.
Diabetes Obes Metab. 2024 Mar 7. doi: 10.1111/dom.15541.
- IVERSEN E, Christensen KM, Walls AB, Eickhoff MK, et al
Performance of new and panel CKD-EPI equations in European adults with type 2
diabetes.
Diabetes Obes Metab. 2024 Mar 6. doi: 10.1111/dom.15536.
- REDDY M, Oliver N
The role of real-time continuous glucose monitoring in diabetes management and
how it should link to integrated personalized diabetes management.
Diabetes Obes Metab. 2024;26 Suppl 1:46-56.
- TURNER LV, Riddell MC
Pre-dinner walks may be superior to post-dinner walks for glucose time in range
in adults with type 1 diabetes on hybrid closed-loop insulin delivery systems.
Diabetes Obes Metab. 2024 Mar 4. doi: 10.1111/dom.15532.
- HOYT JA, Cozzi E, D'Alessio DA, Thompson CC, et al
A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in
type 2 diabetes.
Diabetes Obes Metab. 2024 Mar 4. doi: 10.1111/dom.15533.
- BATDORF HM, Lawes LL, Cassagne GA, Fontenot MS, et al
Accelerated onset of diabetes in non-obese diabetic mice fed a refined high-fat
diet.
Diabetes Obes Metab. 2024 Mar 4. doi: 10.1111/dom.15522.
- CHEN GL, Liu Y, Gao XF, Wu KQ, et al
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity
profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre,
randomized, double-blind, dose escalation study.
Diabetes Obes Metab. 2024;26:1395-1406.
- GUY A, Azab AN, Liberty IF, Afawi Z, et al
Adherence to liraglutide among individuals with overweight and obesity: Patient
characteristics and clinical measures.
Diabetes Obes Metab. 2024;26:1346-1354.
- LAU D, Gamble JM
Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging
signal?
Diabetes Obes Metab. 2024;26:1150-1156.
- HOPE DCD, Ansari S, Choudhury S, Alexiadou K, et al
Adaptive infusion of a glucagon-like peptide-1/glucagon receptor co-agonist
G3215, in adults with overweight or obesity: Results from a phase 1 randomized
clinical trial.
Diabetes Obes Metab. 2024;26:1479-1491.
- BAZYDLO-GUZENDA K, Jarus-Dziedzic K, Gierczak-Pachulska A, Buda P, et al
First-in-human study of CPL207280, a novel G-protein-coupled receptor 40/free
fatty acid receptor 1 agonist, in healthy volunteers after single and multiple
administration.
Diabetes Obes Metab. 2024;26:1376-1385.
- CUKIERMAN-YAFFE T, Ramasundarahettige C, Bosch J, Gerstein HC, et al
Effect of basal insulin and omega 3 fatty acids on cognitive impairment in
dysglycaemia: An exploratory analysis of the ORIGIN trial.
Diabetes Obes Metab. 2024;26:1180-1187.
J Clin Endocrinol Metab
- BOURGONJE AR, Bourgonje MF, Sokooti S, la Bastide-van Gemert S, et al
Plasma calprotectin and new-onset type 2 diabetes in the general population: a
prospective cohort study.
J Clin Endocrinol Metab. 2024 Mar 4:dgae130. doi: 10.1210.
- ALHENC-GELAS F, Marre M
Young onset type2 diabetes: when gluconeogenesis is overfueled and out of
control.
J Clin Endocrinol Metab. 2024 Mar 5:dgae123. doi: 10.1210.
- LIU W, Cai D, Zhang R, Zhang X, et al
A randomized clinical trial for meal bolus decision using learning-based control
in adults with type 2 diabetes.
J Clin Endocrinol Metab. 2024 Mar 7:dgae143. doi: 10.1210.
J Clin Invest
- DEFRONZO RA
SGLT2 inhibitors: cardiorenal metabolic drugs for the ages.
J Clin Invest. 2024;134:e177625.
J Diabetes Complications
- TSUR N, Frankel M, Cahn A, Tsur A, et al
Gestational diabetes and risk of future diabetes in a multi-ethnic population.
J Diabetes Complications. 2024;38:108720.
J Hypertens
- SASAKI N, Maeda R, Ozono R, Yoshimura K, et al
Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular
mortality between normotensive and hypertensive individuals.
J Hypertens. 2024;42:610-619.
- BARCELLOS PAM, Dall'Agnol A, Sandi GM, Remonti LR, et al
Dietary approach for the treatment of arterial hypertension in patients with
diabetes mellitus.
J Hypertens. 2024;42:583-593.
- WANG R, Zhao J, Li L, Huo Y, et al
Associations between lipid-lowering drugs and pregnancy and perinatal outcomes: a
Mendelian randomization study.
J Hypertens. 2024;42:727-734.
JAMA
- ALHIARY R, Gabriele S, Kesselheim AS, Tu SS, et al
Delivery Device Patents on GLP-1 Receptor Agonists.
JAMA. 2024 Feb 5:e240919. doi: 10.1001/jama.2024.0919.
- RUDER K
Diabetic Foot Infections and Amputations Are All Too Common-Here's What Could
Move the Needle.
JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1016.
Metabolism
- ROSENDO-SILVA D, Gomes PB, Rodrigues T, Viana S, et al
Clinical and molecular profiling of human visceral adipose tissue reveals
impairment of vascular architecture and remodeling as an early hallmark of
dysfunction.
Metabolism. 2024;153:155788.
N Engl J Med
- KINNY-KOSTER B, Michalski CW, Loos M
Digital Technology for Diabetes.
N Engl J Med. 2024;390:962.
- TUMMINIA A, Gullo D, Frasca F
Digital Technology for Diabetes.
N Engl J Med. 2024;390:962-963.
- BERG TJ
Digital Technology for Diabetes.
N Engl J Med. 2024;390:963.
- HUGHES MS, Addala A, Buckingham B
Digital Technology for Diabetes. Reply.
N Engl J Med. 2024;390:963-964.
Ophthalmol Retina
- GULKAS S, Salongcay RP, Jacoba CMP, Gomez EDD, et al
Peripheral and Vitreous Pathology in Ultrawide Field Cameras in Diabetic Eyes.
Ophthalmol Retina. 2024 Mar 4:S2468-6530(24)00090.
- ALSHAIKHSALAMA AM, Thompson KN, Patrick H, Lee J, et al
Clinical Characteristics and Surgical Outcomes of Patients Undergoing Pars Plana
Vitrectomy for Proliferative Diabetic Retinopathy.
Ophthalmol Retina. 2024 Mar 4:S2468-6530(24)00087.
- KADERLI ST, Piccoli G, Limoli C, Ginelli S, et al
Clinical features related to optical coherence tomography angiography artifacts
in patients with diabetic macular edema.
Ophthalmol Retina. 2024 Mar 4:S2468-6530(24)00089.
PLoS One
- YUI K, Kanawaku Y, Morita A, Hirakawa K, et al
Time-frequency analysis reveals an association between the specific nuclear
magnetic resonance (NMR) signal properties of serum samples and arteriosclerotic
lesion progression in a diabetes mouse model.
PLoS One. 2024;19:e0299641.
- OLSON PS, Ploylearmsang C, Sibounheuang P, Sookaneknun S, et al
Development of a patient satisfaction questionnaire (PSQ) for diabetes management
in Thailand and Lao PDR.
PLoS One. 2024;19:e0300052.
- LIU B, Si J, Qi K, Li D, et al
Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through
LKB1/AMPK/Nrf2 signaling pathway.
PLoS One. 2024;19:e0296792.
- YANG Y, Cai Z, Qiu S, Xu P, et al
Vision transformer with masked autoencoders for referable diabetic retinopathy
classification based on large-size retina image.
PLoS One. 2024;19:e0299265.
- KIM JS, Kim ES, Hwang HS, Jeong KH, et al
Association between albuminuria and retinal microvascular parameters measured
with swept-source optical coherence tomography angiography in patients with
diabetic retinopathy.
PLoS One. 2024;19:e0295768.
- SMUDJA M, Milenkovic T, Minakovic I, Zdravkovic V, et al
Self-care activities in pediatric patients with type 1 diabetes mellitus.
PLoS One. 2024;19:e0300055.
- YAMAMOTO M, Aoki S, Shinoda S, Ishikawa H, et al
Impact of interpregnancy weight changes and perinatal outcomes: A retrospective
study in Japan.
PLoS One. 2024;19:e0299794.
WMJ
- ZIMMERMANN PN, Baier Manwell LM, Osman F, Feldstein D, et al
Feasibility Study of a Low-Carbohydrate/Time-Restricted Eating Protocol for
Insulin-Using Type 2 Diabetic Patients.
WMJ. 2024;123:11-17.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016